Mobius Life Sciences
Home
About
Investment Criteria
Portfolio
News & Events
Contact
Portfolio
Mobius Life Sciences' Investments
Xenogesis
XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism &...
Keep Reading...
Cellaura Technologies
CellAura Technologies is the premier source of innovative fluorescent screening products for life science research...
Keep Reading...
Haemostatix
Haemostatix is developing first-in-class clotting agents for the treatment of bleeding or ‘haemostasis’. The company...
Keep Reading...
CompanDX
CompanDX is at the leading edge of biomarker discovery, utilising advanced mass spectrometry techniques combined...
Keep Reading...
R5 Pharmaceuticals
BioCity Nottingham also invested in R5 Pharmaceuticals and the company was subsequently sold
© Mobius Life Sciences 2012
Web site design by
OLIK